Cargando…
Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence
SIMPLE SUMMARY: The widely accepted local therapy in extremity giant cell tumor of bone (GCTB) is surgery, in the form of extended intralesional curettage with adequate disease clearance and retention of the limb, wherever possible. Denosumab is a relevant therapy option for advanced GCTB, to benefi...
Autores principales: | Borkowska, Aneta Maria, Szumera-Ciećkiewicz, Anna, Szostakowski, Bartłomiej, Pieńkowski, Andrzej, Rutkowski, Piotr Lukasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100084/ https://www.ncbi.nlm.nih.gov/pubmed/35565419 http://dx.doi.org/10.3390/cancers14092290 |
Ejemplares similares
-
Denosumab treatment of inoperable or locally advanced giant cell tumor of bone
por: Borkowska, Aneta, et al.
Publicado: (2016) -
Diagnostic Utility of Genetic and Immunohistochemical H3-3A Mutation Analysis in Giant Cell Tumour of Bone
por: Wągrodzki, Michał, et al.
Publicado: (2022) -
Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials
por: Zając, Weronika, et al.
Publicado: (2023) -
Clinical Significance of Tumor Microenvironment in Acral Melanoma: A Large Single-Institution Study of Caucasians
por: Borkowska, Aneta Maria, et al.
Publicado: (2021) -
Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials
por: Dudzisz-Śledź, Monika, et al.
Publicado: (2023)